Stay updated on S64315 Combo with Azacitidine in AML Clinical Trial
Sign up to get notified when there's something new on the S64315 Combo with Azacitidine in AML Clinical Trial page.

Latest updates to the S64315 Combo with Azacitidine in AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry, Revision: v3.4.2, was added to the study record history. Older notices about government funding and operating status were removed.SummaryDifference0.8%

- Check21 days agoChange DetectedAdded a government funding lapse notice and a new revision tag (v3.4.1). The prior revision (v3.4.0) was removed.SummaryDifference0.8%

- Check28 days agoChange DetectedVersion history now includes a glossary toggle and color-coded change highlights. The revision label changes from v3.3.4 to v3.4.0 and the No FEAR Act data marker is removed.SummaryDifference1%

- Check42 days agoChange DetectedRevision history now includes v3.3.4 and excludes v3.3.3, which is a minor version-control update to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision entry (v3.3.3) was added to the record history, and the HHS Vulnerability Disclosure link along with the v3.3.2 revision entry were removed from the footer.SummaryDifference0.2%

- Check85 days agoChange DetectedThe Record History shows a new version entry: Revision v3.3.2 replacing v3.3.1, with no visible changes to study details or results. The footer and structure appear unchanged beyond the version note. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to S64315 Combo with Azacitidine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the S64315 Combo with Azacitidine in AML Clinical Trial page.